Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
NEW YORK, April 14, 2020 (GLOBE NEWSWIRE) --
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
If you own shares in any of the companies listed above and
would like to discuss our investigations or have any questions concerning
this notice or your rights or interests, please contact:
Joshua Rubin, Esq.
WeissLaw LLP
1500 Broadway, 16th Floor
New York, NY 10036
(212) 682-3025
(888) 593-4771
stockinfo@weisslawllp.com
Xperi Corporation (NASDAQ:XPER) and TiVo Corporation (NASDAQ:TIVO)
Want Private Access to Benzinga Analyst?
Check out the latest strategies our team of experts are using every week so that you can always adapt to the market like the pros!—Get FULL Access to This Week's Webinar Here.
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Xperi Corporation (NASDAQ:XPER) and TiVo Corporation (NASDAQ:TIVO) in connection with the proposed merger of the two companies. Under the terms of the merger agreement, the shares of XPER and TIVO stockholders will be converted into shares of a new parent company based on a fixed exchange ratio of 0.455 XPER share per existing TIVO share. Upon completion of the merger, TIVO stockholders will own 53.5% and XPER stockholders will own 46.5% of the new parent company. If you own XPER or TIVO shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: http://www.weisslawllp.com/xperi-and-tivo-corporations-investigation/
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH)
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) in connection with the proposed acquisition of the company by AcelRX Pharmaceuticals, Inc. ("ACRX"). Under the terms of the acquisition agreement, shareholders will receive 0.6303 shares of ACRX common stock for each share of TTPH they own, representing implied per-share merger consideration of $0.826 per share based on ACRX's April 13, 2020 closing price of $1.31. If you own TTPH shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: http://www.weisslawllp.com/tetraphase-pharmaceuticals-inc/
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.